EarningsQ2 2019 Earnings Report

Innate Pharma (IDDA) Q2 2019 Earnings Report

1 Followers

DE:IDDA Q2 2019 EPS Results

Actual EPS-€0.08

Consensus EPS―

Beat/Miss―

One Year Ago EPS-€0.29

Actual Revenue€51.22M

Expected Revenue―

Beat/Miss―

YoY Revenue Growth+185.45%

QuarterQ2 2019

Date09/13/2019

TimeBefore Open

Conference CallFriday, September 13, 2019

DE:IDDA Upcoming Earnings

Innate Pharma's next earnings date is estimated for March 25, 2027, based on past reporting schedules.

No earnings call audio is available for this earnings event.

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Mar 25, 2027	2026 (Q4)	-0.25 / -	-0.315	―
Sep 17, 2026	2026 (Q2)	-0.16 / -0.21	-0.26	18.58% (+0.05)
Mar 26, 2026	2025 (Q4)	-0.12 / -0.31	-0.304	-3.47% (-0.01)
Sep 17, 2025	2025 (Q2)	-0.29 / -0.26	-0.301	13.45% (+0.04)
Mar 27, 2025	2024 (Q4)	-0.23 / -0.30	-0.114	-166.15% (-0.19)
Sep 12, 2024	2024 (Q2)	-0.26 / -0.30	0.018	-1728.57% (-0.32)
Mar 21, 2024	2023 (Q4)	-0.38 / -0.11	-0.774	85.23% (+0.66)
Sep 14, 2023	2023 (Q2)	0.08 / 0.02	0.07	-73.75% (-0.05)
Mar 23, 2023	2022 (Q4)	-0.36 / -0.77	-0.332	-132.80% (-0.44)
Sep 15, 2022	2022 (Q2)	0.33 / 0.07	-0.312	122.54% (+0.38)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed